Validation Of The Flemish Montreal Cognitive Assessment (MoCA) For Persons With Hearing Impairment

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

The Montreal Cognitive Assessment (MoCA) is a screening test for detecting cognitive impairment that assesses several cognitive domains (attention and concentration, arithmetic and orientation, memory, etc.). The instructions as well as some test items of the MoCA are presented auditory (spoken). Consequently, performance on the MoCA may be co-dependent on hearing. Therefore, to rule out the possible negative influence of hearing loss on performance on the MoCA, a MoCA for individuals with hearing loss was recently developed. More specifically, the original MoCA was modified by providing the instructions audiovisually (spoken with visual support) as well as by replacing hearing-dependent items. Since replacing items may affect sensitivity and specificity, the MoCA for persons with hearing loss should be revalidated.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 80
View:

• Individuals aged 60 years or older

• Individuals with normal vision (with lenses or glasses if needed)

• Individuals with age-related hearing loss

• Dutch-speaking individuals

• Individuals capable of giving consent to participate in the study themselves

• Individuals still residing in their own homes

• Individuals with an official diagnosis of dementia (Alzheimer's, vascular, or mixed) or mild cognitive impairment. This inclusion criterion applies only to the group with cognitive impairment.

Locations
Other Locations
Belgium
University Ghent Hospital
RECRUITING
Ghent
Contact Information
Primary
Katrien Kestens, PhD
katrien.kestens@ugent.be
003293320865
Backup
Tim Van Langenhove, MD, PhD
tim.vanlangenhove@uzgent.be
Time Frame
Start Date: 2023-09-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 450
Treatments
Individuals (>45 years) with mild cognitive impairment and hearing loss
All tests will be administered.
Individuals (>45 years) with dementia (Alzheimer, vascular or mixed) and hearing loss
All tests will be administered.
Individuals (>45 years) with age-normal cognition and hearing loss
All tests will be administered.
Related Therapeutic Areas
Sponsors
Leads: University Ghent
Collaborators: University Hospital, Ghent

This content was sourced from clinicaltrials.gov